Company profile for Kuur Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of T cells, called natural killer T cells (NKT cells) and innovative chimeric antigen receptor (CAR) construct engineering. In combination, this delivers a very compelling and u...
Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of T cells, called natural killer T cells (NKT cells) and innovative chimeric antigen receptor (CAR) construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Houston Office 2617 Bissonnet St Suite 300 Houston, TX 77005
Telephone
Telephone
Client Website
Website
--
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/ziopharm-lays-off-half-its-staff-after-manufacturing-issues-force-delays/

Max Gelman ENDPTS
29 Sep 2021

https://endpts.com/ziopharm-finds-new-ceo-after-six-month-search-cfo-transition-at-lonza-to-take-place-in-december/

ENDPTS
03 Sep 2021
Ziopharm hires new CEO
Ziopharm hires new CEO

30 Aug 2021

// FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/brain-cancer-biotech-ziopharm-snags-new-brains-for-ceo-post-from-kuur-therapeutics

FIERCEBIOTECH
30 Aug 2021

https://www.globenewswire.com/news-release/2021/05/04/2222922/0/en/Athenex-to-Acquire-Kuur-Therapeutics-to-Expand-Cell-Therapy-Development-with-Off-the-Shelf-Engineered-CAR-NKT-Platform.html

GLOBENEWSWIRE
04 May 2021

https://www.businesswire.com/news/home/20210121005239/en

BUSINESSWIRE
21 Jan 2021

https://endpts.com/months-after-a-major-rebranding-around-car-nkt-cells-kuur-therapeutics-is-offering-a-peek-at-early-results/

Nicole DeFeudis ENDPTS
21 Jan 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty